Literature DB >> 24204398

Natural products in synthesis and biosynthesis.

Jeroen S Dickschat1.   

Abstract

Entities:  

Keywords:  natural products

Year:  2013        PMID: 24204398      PMCID: PMC3817596          DOI: 10.3762/bjoc.9.223

Source DB:  PubMed          Journal:  Beilstein J Org Chem        ISSN: 1860-5397            Impact factor:   2.883


× No keyword cloud information.
This is the second Thematic Series in the Beilstein Journal of Organic Chemistry focused on natural products. While the first Thematic Series summarized recent research work on the biosynthesis and function of natural products [1-2], the present Thematic Series deals with synthetic and biosynthetic aspects. Why the research interest in natural products? Natural products are structurally fascinating as is spectacularly demonstrated by the prominent examples of maitotoxin [3], the largest non-polymer secondary metabolite known to date, or calicheamycin (Figure 1), which possibly holds the record in carrying the most diverse functional groups including an enediyne subunit, a deoxysugar, an aminosugar, a hydroxylamine linkage between two sugar subunits, a carbamate, an aromatic iodide, a thioester, and a trisulfide [4]. Natural products have also been used by humankind since ancient times and are part of our traditions and culture, as is evident from the widespread consumption of coffee, tea, tobacco and cocoa, drugs that all contain alkaloids with stimulating effects. More importantly, starting from their usage in traditional medicine natural products – and today also compounds inspired by natural products – are indispensable in the treatment of various threatening infectious diseases. The rapid spreading of antibiotic resistances and the comeback of some infectious diseases already claimed to be eliminated should sharpen our minds for the beneficial roles of natural products in medicine as well as their responsible use. This should be a strong appeal upon the responsibility of both researchers and decision makers in the academic sciences and the pharmaceutical industry.
Figure 1

Calicheamycin.

Calicheamycin. Why should we have a look at the synthetic and biosynthetic aspects of natural products in this Thematic Series? Of course, the chemistry of nature and as it is used by chemists is one and the same and makes use of the same intrinsic reactivity of molecules. It is fascinating to see that a particular chemical reaction, believed to be invented by man, is in fact already used for millions – sometimes even billions – of years by Mother Nature. An interesting example is the discovery of the Diels–Alder reaction in the 1920s and its later enhancement into an enantioselective reaction by the development of chiral catalysts. But a Diels–Alder reaction also occurs in the biosynthesis of lovastatin and is likely catalysed by a Diels–Alderase [5], a natural analogue of man-made chiral catalysts! Beyond such fascinating examples of comparing natural to artificial systems it is their interplay that may provide the best solutions to some of the most urgent problems of our time. A perfect example is artemisinin, a terpenoid natural product from Artemisia annua, which is highly efficient in the treatment of malaria. The problem is that the plant produces only small and variable amounts, thereby making the isolation procedure difficult and expensive. Neither biotechnology nor chemistry were able to provide a solution on their own, but the combination of the heterologous production of an advanced intermediate in yeast [6] and its further elaboration by chemical synthesis [7] procures sufficient quantities of artemisinin at a reasonable price. An impressive demonstration of the effectiveness of multi-disciplinary research. I would like to thank the highly professional team of the Beilstein-Institut for a very pleasant cooperation on this Thematic Series. I wish you, the reader, joy and fun with this Thematic Series and – at the best – a new impetus for your own future research! Jeroen S. Dickschat Braunschweig, September 2013
  6 in total

1.  Continuous-flow synthesis of the anti-malaria drug artemisinin.

Authors:  François Lévesque; Peter H Seeberger
Journal:  Angew Chem Int Ed Engl       Date:  2012-01-16       Impact factor: 15.336

2.  On the structure of maitotoxin.

Authors:  K C Nicolaou; Michael O Frederick
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 3.  Biosynthesis of lovastatin and related metabolites formed by fungal iterative PKS enzymes.

Authors:  Chantel D Campbell; John C Vederas
Journal:  Biopolymers       Date:  2010-09       Impact factor: 2.505

4.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast.

Authors:  Dae-Kyun Ro; Eric M Paradise; Mario Ouellet; Karl J Fisher; Karyn L Newman; John M Ndungu; Kimberly A Ho; Rachel A Eachus; Timothy S Ham; James Kirby; Michelle C Y Chang; Sydnor T Withers; Yoichiro Shiba; Richmond Sarpong; Jay D Keasling
Journal:  Nature       Date:  2006-04-13       Impact factor: 49.962

5.  Calicheamicins, a novel family of antitumor antibiotics: taxonomy, fermentation and biological properties.

Authors:  W M Maiese; M P Lechevalier; H A Lechevalier; J Korshalla; N Kuck; A Fantini; M J Wildey; J Thomas; M Greenstein
Journal:  J Antibiot (Tokyo)       Date:  1989-04       Impact factor: 2.649

6.  Biosynthesis and function of secondary metabolites.

Authors:  Jeroen S Dickschat
Journal:  Beilstein J Org Chem       Date:  2011-12-05       Impact factor: 2.883

  6 in total
  1 in total

1.  Natural products in synthesis and biosynthesis II.

Authors:  Jeroen S Dickschat
Journal:  Beilstein J Org Chem       Date:  2016-03-03       Impact factor: 2.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.